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Abstract
OBJECTIVE—To evaluate trends and associations of hypertensive disorders of pregnancy with 
stroke risk and test the hypothesis that hypertensive disorders of pregnancy-associated stroke 
results in higher rates of stroke-related complications than pregnancy-associated stroke without 
hypertensive disorders.
METHODS—A cross-sectional study was performed using 81,983,216 pregnancy 
hospitalizations from the 1994–2011 Nationwide Inpatient Sample. Rates of stroke 
hospitalizations with and without these hypertensive disorders were reported per 10,000 
pregnancy hospitalizations. Using logistic regression, adjusted odds ratios (OR) with 95% 
confidence intervals were obtained.
RESULTS—Between 1994–1995 and 2010–2011, the nationwide rate of stroke with 
hypertensive disorders of pregnancy increased from 0.8 to 1.6 per 10,000 pregnancy 
hospitalizations (103%), whereas the rate without these disorders increased from 2.2 to 3.2 per 
10,000 pregnancy hospitalizations (47%). Women with hypertensive disorders of pregnancy were 
5.2 times more likely to have a stroke than those without. Having traditional stroke risk factors 
(eg, congenital heart disease, atrial fibrillation, sickle cell anemia, congenital coagulation defects) 
substantially increased the stroke risk among hypertensive disorders of pregnancy hospitalizations: 
from adjusted OR 2.68 for congenital coagulation defects to adjusted OR 13.1 for congenital heart 
disease. Stroke-related complications were increased in stroke with hypertensive disorders of 
pregnancy compared with without (from adjusted OR 1.23 for nonroutine discharge to adjusted 
OR 1.93 for mechanical ventilation).
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CONCLUSION—Having traditional stroke risk factors substantially increased the stroke risk 
among hypertensive disorders of pregnancy hospitalizations. Stroke with hyper-tensive disorders 
in pregnancy had two distinctive characteristics: a greater increase in frequency since the 
mid-1990s and significantly higher stroke-related complication rates.
Despite the fact that hypertensive disorders of pregnancy are prevalent and a strong risk 
factor for pregnancy-associated stroke, there is a dearth of literature examining its trends, 
etiologies, risk factors, and outcomes.1,2 Several previous analyses have showed a temporal 
increase in the number of pregnancy hospitalizations with stroke during 1994–2007 in the 
United States: 47% for antenatal hospitalizations and 83% for postpartum hospitalizations.2 
The frequency of preeclampsia has also increased by approximately 25%,3 worsening in 
severity over the time period.4 In this study, we elucidate pregnancy-associated stroke using 
the Nationwide Inpatient Sample by 1) estimating the changes in overall pregnancy 
associated stroke as well as stroke with and without hypertensive disorders of pregnancy 
from 1994–1995 to 2010–2011; 2) demonstrating how traditional stroke risk factors affect 
the relationship between these hypertensive disorders of pregnancy and stroke; and 3) 
assessing whether stroke with hypertensive disorders of pregnancy has higher stroke-related 
complications rates than stroke without them.
MATERIALS AND METHODS
Data for the study were derived from the Nationwide Inpatient Sample, which is maintained 
by the Agency for Healthcare Research and Quality as part of the Healthcare Cost and 
Utilization Project. A sample of nonfederal community hospitals is selected based on 
geographic region, teaching status, ownership, rural or urban location, and number of beds 
to create a sample that is maximally representative of all U.S. hospital admissions. For each 
hospital admission, demographic and discharge destination data elements and up to 15 
diagnoses and procedures coded using the International Classification of Disease, 9th 
Revision, Clinical Modification (ICD-9-CM) codes are recorded based on billing data. 
Because the data are public and deidentified, this study was exempt from review by the 
institutional review board for the Centers for Disease Control and Prevention as well as for 
the Massachusetts General Hospital. We identified pregnancy-related admissions from 1994 
to 2011 for women ages 15–44 years (Table 1). Pregnancy stage was denoted using the fifth 
digit modifiers on ICD-9-CM codes. Antenatal hospitalizations were defined as nondelivery 
admissions during pregnancy, and postpartum hospitalizations were defined as separate from 
delivery hospitalizations up to 6 weeks postpartum with details described elsewhere.5,6 Our 
study used the list of ICD-9-CM codes proposed by the Joint Commission to identify 
hospitalizations with stroke in administrative databases.7 The following ICD-9-CM codes 
listed at any position were used to identify diagnoses of ischemic stroke (433.01, 433.10, 
433.11, 433.21, 433.31, 433.81, 433.91, 434.00, 434.01, 434.11, 434.91, and 436), 
subarachnoid hemorrhage (430), intracerebral hemorrhage (431), and transient ischemic 
attack (435). International Classification of Diseases, 9th Revision, Clinical Modification 
codes for unspecified stroke during pregnancy or iatrogenic stroke (674.0 and 997.02, 
respectively) were included in our analysis for completeness. These diagnoses were then 
combined into three groups for analysis based on stroke subtype: hemorrhagic stroke 
(subarachnoid hemorrhage and intracerebral hemorrhage), ischemic stroke, and other 
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(transient ischemic attack and unspecified stroke). International Classification of Diseases, 
9th Revision, Clinical Modification codes for nonpyogenic thrombosis of intracranial 
venous sinus (437.6), phlebitis and thrombophlebitis of intracranial venous sinuses (325) 
and peripartum phlebitis and thrombosis, cerebral venous thrombosis, and thrombosis of 
intracranial venous sinus (671.5) were excluded because these conditions do not necessarily 
result in a stroke.
Hospitalizations with hypertensive disorders of pregnancy were identified by using ICD-9-
CM codes: 642.0x, 642.1x, 642.2x, 642.3x, 642.4x, 642.5x, 642.6x, 642.7x, 642.9x, and 
401.x-405.xx. The ICD-9-CM code 780.39 was used to indicate stroke-associated seizure 
and code 642.6 for seizure indicating eclampsia.
As required by the Nationwide Inpatient Sample data user agreement to protect individual 
identity, data cells containing 10 or fewer observations were eliminated.8 The unit of 
analysis was a hospitalization, not an individual. All analyses were weighted to take into 
account complex survey methodology and to generate national estimates. These analyses 
were performed using SAS-callable 9.3 Sudaan 11.
For the trend analysis, rates per 10,000 pregnancy hospitalizations and tests for linear trend 
were calculated for overall pregnancy-related stroke and hypertensive and nonhypertensive 
disorders of pregnancy-associated stroke (Fig. 1). Orthogonal polynomial coefficients were 
calculated recursively by the method of Fisher and Yates for linear trend testing.9 The 
significance level used to test linear trends was set at 99% (ie, P=5.01 threshold) given our 
very large data set. As recommended by the Agency for Healthcare Research and Quality, 
the Nationwide Inpatient Sample Trends Supplemental Files (NIS-Trends) for trend analysis 
were used to account for temporal changes in sampling and weighting strategy.10 Odds 
ratios (ORs) and their 95% confidence intervals (CIs) were obtained from multivariable 
logistic regression analysis to assess changes in stroke prevalence from 1994–1995 to 2010–
2011. Other study intervals (1996–1997, 1998–1999, and so on) were also included in the 
models as categorical variables. This analysis was adjusted for changes in the distribution of 
maternal age, insurance coverage (payer), race–ethnicity, delivery mode, multiple gestation, 
hospitalizations with hypertensive disorders of pregnancy, hemorrhage during pregnancy, 
and known stroke-related maternal comorbid conditions (congenital heart disease, atrial 
fibrillation, primary thrombocytopenia, migraine, systemic lupus erythematosus, sickle cell 
anemia, valve disorders, congenital coagulation defects, and preexisting diabetes). 
Hypertensive disorders of pregnancy admissions ORs and their 95% CI were analyzed by 
multivariable logistic regression to assess the effect of hypertensive disorders of pregnancy 
plus comorbid conditions, adjusting for age, race–ethnicity, delivery mode, payer, hospital 
region, hospital teaching status, and study interval. That analysis was restricted to 
hypertensive disorders of pregnancy admissions (Table 2). These same methods were then 
applied to investigate the effect of hypertensive disorders of pregnancy on stroke-related 
complications, including mechanical ventilation, seizure, pneumonia, prolonged hospital 
stay, and death during hospitalization. We used the 97th percentile (5 or more inpatient 
days) as our definition of prolonged hospital stay as the categorical outcome variable. Each 
model for stroke-related complications was also adjusted for length of stay as a continuous 
predictor variable, except for the models for prolonged length of stay. Analyses of 
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temporary tracheostomy and percutaneous gastrostomy tube were limited to survivors 
(Table 3). Nonroutine discharge was defined as in-hospital death or discharge to any 
destination other than home.
Additional analyses were performed to examine the differences in risk factors and 
complications between hemorrhagic and ischemic stroke subtype. Both analyses are adjusted 
in a similar manner to the analyses described for Tables 2 and 3. The ORs for stratified 
stroke subtypes are available in Appendix 1 (available online at http://links.lww.com/AOG/
A586) and Appendix 2 (available online at http://links.lww.com/AOG/A587).
All other values represent simple proportions from weighted data.
RESULTS
We identified 81,983,216 pregnancy hospitalizations occurring between the years 1994 and 
2011, among which there were 31,673 hospitalizations with strokes, for a frequency of 3.8 
strokes per 10,000 pregnancy-related hospitalizations. Of these, 9,890 (31.2%) occurred in 
patients with hypertensive disorders of pregnancy and 21,783 (68.8%) were in patients 
without these disorders.
Table 1 compares the demographic data and clinical conditions in the pregnancy 
hospitalizations with and without hypertensive disorders of pregnancy: the former were 
more likely to occur in older age (older than 35 years) or in women of African American 
race. Between 1994–1995 and 2010–2011, overall pregnancy-related stroke increased by 
61.5% (from 3.0 to 4.8 per 10,000 pregnancy hospitalizations) (Fig. 1). The stroke rates with 
hypertensive disorders of pregnancy increased from 0.8 to 1.6 per 10,000 pregnancy 
hospitalizations (102.6%) compared with an increase from 2.2–3.2 per 10,000 pregnancy 
hospitalizations (46.6%) for those without these disorders (P for linear trend for both <.001). 
The rates of hypertensive disorders of pregnancy increased by 71% (P for linear trend <.
001). We noted a particular increase in all three categories of pregnancy-associated stroke in 
the time interval from 1998–1999 to 2001–2002 without an accompanying change in coding. 
Adjustment for the changes in prevalence of hospitalizations with hypertensive disorders of 
pregnancy, payer, age, race–ethnicity, delivery mode, multiple gestation, hemorrhage during 
pregnancy, and maternal comorbid conditions explained most increases in the overall stroke 
prevalence from 1994–1995 to 2010–2011 (unadjusted OR compared with adjusted OR with 
95% CI for 2010–2011 with 1994–1995 as the referent group: OR 1.61, 95% CI 1.39–1.87 
compared with adjusted OR 1.19, 95% CI 1.03–1.37). The adjustments only partially 
explained increases in the prevalence of stroke with hypertensive disorders of pregnancy 
(unadjusted OR 2.02, 95% CI 1.59–2.57 compared with adjusted OR 1.69, 95% CI 1.33–
2.15) and stroke without hypertensive disorders of pregnancy (unadjusted OR 1.47, 95% CI 
1.24–1.73 compared with adjusted OR 1.18, 95% CI 1.00–1.39). This adjustment also only 
partially explained increases in the prevalence of hypertensive disorders of pregnancy 
(unadjusted OR 1.71, 95% CI 1.64–1.79 compared with adjusted OR 1.57, 95% CI 1.50–
1.63).
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The majority of pregnancy-related strokes occurred outside of the delivery period (66%): 
32% antenatally and 34% postpartum. In the hypertensive group, 15% of strokes occurred 
antenatally and 42% occurred postpartum. In the nonhypertensive group, 40% of the strokes 
occurred antenatally and 30%, postpartum (Appendix 3, available online at http://
links.lww.com/AOG/A588). Hospitalizations with hypertensive disorders of pregnancy were 
5.2 (95% CI 4.9–5.6) times more likely to have the ICD-9-CM code for stroke (data not 
shown). Traditional stroke risk factors, including congenital coagulation defects, valve 
disorders, sickle cell anemia, systemic lupus erythematosus, migraine, primary 
thrombocytopenia, atrial fibrillation and congenital heart disease, conferred additional risk 
of pregnancy-related stroke among hospitalizations with hypertensive disorders of 
pregnancy (adjusted OR ranging from 1.33 [95% CI 1.04–1.71] for postpartum hemorrhage 
to 13.1 [95% CI 9.09–18.9] for congenital heart disease) (Table 2). Moreover, most 
traditional stroke risk factors had a stronger association with ischemic stroke than with 
hemorrhagic stroke, except for congenital coagulation defects, which had a stronger 
association with hemorrhagic stroke (Appendix 1, http://links.lww.com/AOG/A586).
Among pregnancy hospitalizations with stroke and hypertensive disorders of pregnancy, 
there were higher rates of complications (per 10,000 hospitalizations) than in 
hospitalizations with stroke without these hypertensive disorders, including the need for 
mechanical ventilation, seizure, pneumonia, prolonged hospital stay, and death during 
hospitalization (adjusted OR ranging from 1.23, 95% CI 1.08–1.40 for nonroutine discharge 
to 1.93, 95% CI 1.63–2.25 for mechanical ventilation) (Table 3). No significant differences 
were found for temporary tracheostomy and percutaneous gastrostomy tube placements 
between the two groups. Hemorrhagic stroke had higher complication rates and the direction 
of associations remained the same except for in-hospital mortality and nonroutine discharge 
for ischemic stroke (Appendix 2, http://links.lww.com/AOG/A587).
DISCUSSION
Despite a 10-year decline in overall stroke prevalence and mortality among older adults in 
the United States,11 our data show that the rate of pregnancy-related stroke increased by 
61.5% between 1994–1995 and 2010–2011. Rates of stroke with hypertensive disorders of 
pregnancy increased disproportionately. The rate of hypertensive disorders of pregnancy 
also increased during the study period.2,3 Known risk factors for each such as heart disease, 
hypertensive disorders, maternal comorbid conditions, and advanced maternal age have been 
implicated.1,12 Adjustment for the changes in these factors in our analysis partially 
explained the substantial observed increases in the hypertensive disorders of pregnancy-
associated stroke prevalence. Our additional findings that traditional cardiac and noncardiac 
stroke risk factors impart independent stroke risk in women with hypertensive disorders of 
pregnancy are biologically and clinically plausible. Preeclampsia involves systemic 
endothelial dysfunction and elevated coagulation beyond that of normal pregnancy.13,14 
Hypertension is an established risk factor for both hemorrhagic and ischemic stroke.15 
Ischemic stroke can be caused by large artery atherosclerosis, small vessel occlusion, or 
cardioembolism, all of which could be increased in hypertensive disorders of pregnancy.16 
Whether the predisposition for stroke in hypertensive pregnant patients is genetic, acquired, 
or both is poorly understood. There is evidence that these women are at risk for stroke 
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peripartum and later in life17 and there is a heightened awareness of the need to standardize 
and improve their care.18 To facilitate the timely recognition, diagnosis, and management of 
the disease, the American College of Obstetricians and Gynecologists Task Force on 
Hypertension has revised the definition of preeclampsia such that proteinuria is not an 
absolute requirement for diagnosis.19 Women with a history of early-onset preeclampsia and 
preterm birth or preeclampsia in more than one prior pregnancy are now instructed to 
receive low-dose aspirin to lower the risk of preeclampsia. Our results confirmed that both 
the ante- and postpartum periods are times of vulnerability for stroke and preventive 
therapy, diagnostic tests, and treatments should be targeted accordingly. Severe hypertension 
(systolic blood pressure 160 mm Hg or higher or diastolic blood pressure 110 mm Hg or 
higher) treatment, twice-weekly antepartum blood pressure checks, and blood pressure 
monitoring for a minimum of 72 hours postpartum and at 7–10 days postpartum in patients 
with hypertension are advocated.19 Because nonsteroidal antiinflammatory medications can 
exacerbate hypertension, they should be used with discretion in hypertensive patients.19
The American Heart Association endorses treatment of moderate hypertension in pregnancy 
(systolic blood pressure between 150 and 159 mm Hg or diastolic blood pressure between 
100 and 109 mm Hg) as well as severe hypertension, although they acknowledge that the 
maternal–fetal risk–benefit ratios are not well established.17 Further investigation at the 
population level is needed to determine whether these interventions will reduce hyper-
tensive disorders of pregnancy-associated stroke.
Because stroke in the young is often mistaken for more benign occurrences such as migraine 
or seizure,20 these patients may miss the opportunity to benefit from deficit-sparing 
therapies. Tissue plasminogen activator has been classified as a pregnancy category C drug, 
historically excluding pregnant women from clinical trials demonstrating its effectiveness 
for ischemic stroke thrombolysis.21 However, recent published case reports and expert 
opinions espouse the application of intraarterial and intravenous thrombolysis in eligible 
pregnant and postpartum patients with ischemic stroke.21–23
We hypothesized that patients with hypertensive disorders of pregnancy would have more 
severe stroke-related complications than patients without hypertensive disorders of 
pregnancy as a result of a higher proportion of hemorrhagic stroke and its often poorer 
outcomes.24–26 However, the increased odds of severe stroke complications found in our 
hypertensive disorders of pregnancy cohort were independent of stroke subtype. It is 
possible that the patients with hemorrhagic stroke were more likely to die, and the survivors 
were more similar to the ischemic stroke survivors.
Our study has several limitations. Although the National Inpatient Sample allows the 
investigation of a large number of data points for stroke, a rare event, these data are from 
ICD-9-CM codes collected for billing purposes. Validation studies suggest that the codes for 
stroke and hypertensive disorders of pregnancy generally have high specificity but more 
limited sensitivity.3,27–29 Given the high specificity of the diagnosis of the exposure and 
outcomes, our estimates of relative risk in the analysis of risk factors and the association 
with adverse outcomes should be relatively unbiased. The hospitalization rate for 
postpartum stroke may have been underestimated, because those occurring within 6 weeks 
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can be mis-classified as nonpregnancy hospitalizations.2 International Classification of 
Diseases, 9th Revision, Clinical Modification designations do not identify hemolysis, 
elevated liver enzymes, and low platelet count (HELLP), which is presumably coded as 
severe preeclampsia. With its marked thrombocytopenia, patients with HELLP may have a 
different stroke risk from those with severe preeclampsia and normal platelet count.
Because our units of measure are hospitalizations, not individuals, we could not account for 
multiple admissions or collect clinical data such as body mass index, severity of 
hypertension, or use of antihypertensive therapy. These factors may have contributed to the 
secular trends observed. The proportion of unclassified race–ethnicity was high (20–25%), 
because several states do not report race–ethnicity to the Healthcare Cost and Utilization 
Project. Although we adjusted for missing data in the models by creating a “missing” group, 
our estimates may not fully account for the confounding effects of race. In addition, the 
ICD-9-CM code 674.0x “cerebrovascular disorders in the puerperium” is often used alone in 
hospital discharge records such that specific stroke subtype may not available in some cases.
Stroke in young adults has historically been under-diagnosed.30 The introduction of 
magnetic resonance imaging in 1994 with widespread use by year 200031 greatly enhanced 
minor ischemic stroke detection as did refinement of stroke diagnostic criteria.32 Although 
this may have contributed to the increasing rates of recognition and reported incidence of 
stroke from 1994–1995 to 2000–2001, there continued to be steady and robust increases 
beyond year 2000 in our study.
In conclusion, stroke in patients with hypertensive disorders of pregnancy had two 
distinctive characteristics: a faster increase in frequency since the mid-1990s likely 
attributable, in part, to the rise in hypertensive disorders of pregnancy and maternal 
comorbidities and a significantly higher rate of stroke-related complications. Also, 
traditional cardiac and noncardiac risk factors for stroke conferred additional independent 
risk of stroke in these vulnerable women. These results highlight the need for continued 
vigilance on the part of care providers regarding hypertensive disorders of pregnancy and 
stroke risk factors, presentation, and diagnosis. Continued education about the management 
of preeclampsia and other pregnancy-related hypertensive disorders, and preventive and 
postacute event therapy for pregnancy-related stroke is of paramount importance.
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Table 1
Patient Demographic Information: Pregnancy Hospitalizations, Nationwide Inpatient Sample, 1994–2011
Pregnancy Hospitalizations









of Pregnancy Without 
Stroke (n=6,176,848)
Without Hypertensive 
Disorders of Pregnancy 
or Stroke (n=75,774,695)
Age (y)
    15–24 2,486 (25.1) 5,740 (26.4) 2,068,206 (33.5) 27,087,409 (35.7)
    25–34
* 4,617 (46.7) 11,276 (51.8) 2,975,974 (48.2) 38,191,483 (50.4)
    Older than 35
* 2,715 (27.5) 4,736 (21.7) 1,113,919 (18.0) 10,290,055 (13.6)
    Missing
* 72 (0.7) 32 (0.1) 18,750 (0.3) 205,748 (0.3)
Race or ethnicity
    White
* 2,877 (29.1) 8,995 (41.3) 2,551,041 (41.3) 31,645,801 (41.8)
    African American
* 2,641 (26.7) 3,773 (17.3) 1,032,702 (16.7) 8,723,547 (11.5)
    Hispanic 1,478 (15.0) 2,776 (12.7) 842,248 (13.6) 12,599,529 (16.6)
    Other 656 (6.6) 1,237 (5.7) 332,386 (5.4) 5,369,660 (7.1)
    Missing 2,238 (22.6) 5,003 (23.0) 1,418,472 (23.0) 17,436,158 (23.0)
Primary payer
    Public
* 4,578 (46.3) 8,616 (39.5) 2,440,210 (39.5) 30,251,779 (39.9)
    Private
* 4,566 (46.2) 11,362 (52.2) 3,349,159 (54.2) 40,010,509 (52.8)
    Self pay, no charge, or other 747 (7.5) 1,805 (8.3) 387,480 (6.3) 5,512,408 (7.3)
Mode of delivery
    Cesarean
* 2,972 (30.1) 3,530 (16.2) 2,381,491 (38.6) 17,341,295 (22.9)
    Vaginal
* 6,918 (69.9) 18,253 (83.8) 3,795,357 (61.4) 58,433,401 (77.1)
Multiple gestation
    Yes 138 (1.4) 203 (0.9) 245,874 (4.0) 1,322,421 (1.7)
    No 9,752 (98.6) 21,580 (99.1) 5,930,974 (96.0) 74,452,274 (98.3)
Hospital region
    Northeast 1,517 (15.3) 3,921 (18.0) 960,519 (15.5) 13,303,443 (17.6)
    Midwest 2,011 (20.3) 4,866 (22.3) 1,327,626 (21.5) 16,756,597 (22.1)
    South 4,145 (50.0) 8,276 (38.0) 2,618,691 (42.4) 27,154,679 (35.8)
    West 2,216 (22.4) 4,720 (21.7) 1,270,012 (20.6) 18,559,976 (24.5)
Hospital teaching status
    Rural 470 (4.8) 1,342 (6.2) 744,796 (12.1) 9,391,442 (12.4)
    Urban nonteaching 3,120 (31.5) 6,610 (30.3) 2,231,691 (36.1) 31,403,776 (41.5)
    Urban teaching 6,244 (63.1) 13,709 (62.9) 3,167,364 (51.3) 34,660,121 (45.7)
    Missing 56 (0.6) 122 (0.6) 32,997 (0.5) 319,757 (0.4)
Data are n (%).
*
The categories above were determined to be statistically significant (P<.01) in a univariate comparison between hypertensive disorders of 
pregnancy and nonhypertensive disorders of pregnancy-associated stroke.
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Table 2
Rates and Odds Ratios
*
 for Stroke by Selected Risk Factors Among Pregnancy Hospitalizations With 
Hypertensive Disorders of Pregnancy: The 1994–2011 Nationwide Inpatient Sample (n = 6,186,738)
Total No. of Hospitalizations 
With Hypertensive 
Disorders of Pregnancy






OR (95% CI) of Having Stroke for 
Hospitalizations With Risk Factor
*






Congenital heart disease 7,535 151 200.4±0.36 12.94 (9.01–18.58) 13.10 (9.09–18.90)
Atrial fibrillation 3,058 52 170.0±0.51 10.91 (5.99–19.89) 8.13 (4.43–14.91)
Primary thrombocytopenia 7,242 62 85.6±0.26 5.46 (3.03–9.84) 5.50 (3.05–9.93)
Migraine 40,920 314 76.7±0.10 4.96 (3.79–6.49) 4.48 (3.41–5.88)
Systemic lupus erythematosus 22,859 125 54.7±0.11 3.45 (2.31–5.17) 2.89 (1.93–4.33)
Sickle cell anemia 39,307 138 35.1±0.07 2.22 (1.52–3,25) 1.58 (1.07–2.32)
Valve disorders 61,786 291 47.1±0.06 3.01 (2.31–3.93) 2.76 (2.12–3.60)
Congenital coagulation defects 36,376 146 40.1±0.07 2.54 (1.77–3.65) 2.68 (1.85–3.88)
Postpartum hemorrhage 163,629 346 21.1±0.02 1.33 (1.04–1.71) 1.33 (1.04–1.71)
Preexisting diabetes 222,485 466 20.9±0.02 1.33 (1.06–1.66) 1.09 (0.86–1.36)
SE, standard error; OR, odds ratio; CI, confidence interval.
*
Referent group: hypertensive disorders of pregnancy hospitalizations without selected risk factor. For example, for hospitalizations with 
congenital heart disease, the referent group is hospitalizations without congenital heart disease.
†
Adjusted for age, race–ethnicity, mode of delivery, study period, region, and hospital teaching status.
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Table 3
Rates and Odds Ratios
*†
 for Stroke-Related Complications by Hypertensive Disorders of Pregnancy Status 
Among Pregnancy Hospitalizations With Stroke: The 1994–2011 Nationwide Inpatient Sample (n=31,673)
Total No. of Stroke Hospitalizations 
With Complications
Rate (SE) of Complication/10,000 
Stroke Hospitalizations
OR (95% CI) of Having 
Complication for Hospitalizations 





































Mechanical ventilation 2,366 2,246 1,081.2±0.48 2,270.9±0.96 2.41 (2.09–2.79) 1.93 (1.63–2.25)
Pneumonia 475 406 218.1±0.23 410.5±0.47 1.92 (1.41–2.61) 1.78 (1.26–2.51)
Seizure 1,897 1,199 870.9±0.43 1,212.3±0.75 1.45 (1.26–1.71) 1.29 (1.08–1.55)
Died during hospitalization 974 785 447.1±0.32 793.7±0.59 1.85 (1.49–2.28) 1.29 (1.02–1.64)
Prolonged hospital stay 9,071 5,903 4,164.3±0.83 5,968.7±1.15 2.08 (1.87–2.31) 1.24 (1.08–1.42)
Nonroutine discharge
‡ 15,563 6,268 7,144.6±0.75 6,337.7±1.13 1.44 (1.29–1.62) 1.23 (1.08–1.40)
Percutaneous gastrostomy tube
§ 397 190 182.2±0.20 192.1±0.32 1.11 (0.75–1.64) 1.04 (0.64–1.68)
Temporary tracheostomy
§ 488 198 224.0±0.22 200.2±0.33 0.91 (0.61–1.36) 0.78 (0.45–1.34)
SE, standard error; OR, odds ratio; CI, confidence interval.
*
Referent group: hospitalizations with nonhypertensive disorders of pregnancy-associated stroke.
†
Adjusted for age, race–ethnicity, mode of delivery, study period, length of stay, hospital characteristics, and stroke subtype. Prolonged hospital 
stay was not adjusted for length of stay.
‡
Nonroutine discharge was defined as in-hospital death or discharge to any destination other than home.
§
Among survivors.
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